JPS51121511A - Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium - Google Patents

Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium

Info

Publication number
JPS51121511A
JPS51121511A JP51034585A JP3458576A JPS51121511A JP S51121511 A JPS51121511 A JP S51121511A JP 51034585 A JP51034585 A JP 51034585A JP 3458576 A JP3458576 A JP 3458576A JP S51121511 A JPS51121511 A JP S51121511A
Authority
JP
Japan
Prior art keywords
polysaccharid
adduct
production
acid extracted
vaccine based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51034585A
Other languages
Japanese (ja)
Inventor
Deyusuuru Danteruran Rushiyan
Norumie Jieraaru
Marii Bineru Annu
Seeru Yuuberu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of JPS51121511A publication Critical patent/JPS51121511A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP51034585A 1975-04-02 1976-03-31 Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium Pending JPS51121511A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7510252A FR2305990A1 (en) 1975-04-02 1975-04-02 PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS

Publications (1)

Publication Number Publication Date
JPS51121511A true JPS51121511A (en) 1976-10-23

Family

ID=9153417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51034585A Pending JPS51121511A (en) 1975-04-02 1976-03-31 Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium

Country Status (6)

Country Link
JP (1) JPS51121511A (en)
BE (1) BE839893A (en)
DE (1) DE2613943C3 (en)
ES (1) ES446637A1 (en)
FR (1) FR2305990A1 (en)
GB (1) GB1543962A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2444464A1 (en) 1978-12-19 1980-07-18 Fabre Sa Pierre PURIFIED BACTERIAL PROTEOGLYCANS, PROCESS FOR THEIR PREPARATION AND VACCINE CONTAINING THEM
FR2471785A1 (en) * 1979-12-21 1981-06-26 Fabre Sa Pierre RIBOSOMAL RNA-BASED IMMUNOSTIMULANT PREPARATIONS AND PROCESS FOR THE PREPARATION OF RNA
FR2475900A1 (en) * 1980-02-20 1981-08-21 Fabre Sa Pierre VACCINE COMPLEX CONTAINING A SPECIFIC ANTIGEN AND VACCINE CONTAINING SAME
FR2596064B1 (en) * 1986-03-18 1990-02-02 Pf Medicament INDUSTRIAL PROCESSES FOR THE MANUFACTURE OF RIBOSOMAL VACCINES AND RIBOSOMAL VACCINES OBTAINED
AR055311A1 (en) 2006-02-17 2007-08-15 H P B S A SOLID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATE BENIGN HYPERPLASIA, PROCEDURE FOR THEIR ELABORATION AND TREATMENT METHOD

Also Published As

Publication number Publication date
BE839893A (en) 1976-09-22
DE2613943B2 (en) 1979-07-05
FR2305990A1 (en) 1976-10-29
ES446637A1 (en) 1977-06-01
DE2613943A1 (en) 1976-10-14
GB1543962A (en) 1979-04-11
FR2305990B1 (en) 1980-01-25
DE2613943C3 (en) 1980-03-06

Similar Documents

Publication Publication Date Title
JPS55148099A (en) Production of 9 alphaa hydroxyandrostendione by microorganism
CS194234B2 (en) Method of production of the bis-/dihydrixypropylamides/ of the acid 5-hydroxypropionylamino-2,4,6-troiodisophtale
GB1551829A (en) Process for the preparation of dispersions
CS179949B2 (en) Method for production of novel d-homopregn-4-ene 3,20-diones
JPS51121511A (en) Production of vaccine based on polysaccharid adduct nucleotic acid extracted from microorganism bacterium
GR63123B (en) Preparation process of novel 1,4-diphenyl-3-pyrazolin-5-ones
ES441404A1 (en) Process of preparing 5-fluoro-2-methyl-1-(paramethylsulfinylbenzylidene)-indenyl-3-acetic acid
IT1054382B (en) METHOD FOR THE MANUFACTURE OF L CID ACID 2 HYDROXY 2 FENYL R 1 CYCLEHEXANCARBOXYL
JPS5254020A (en) Set for testng bacterium
PT65260B (en) Process for the preparation of polyacetovinyl dispersions
JPS5261288A (en) Production of cholesterol oxidase
GB1543039A (en) Process for the preparation of polyisobutene-substituted succinic anhydride
JPS5251087A (en) Microorganism cultivating apparatus
PT65030A (en) Process for the preparation of novel 4,4-diaryl-2-hydroxybutylamines
CS190550B2 (en) Method of producing 6,11-dihydro-11-oxodibenz/b,e/-oxepinalkanoic acid
JPS51112586A (en) Microorganism cultivating apparatus
GB1531635A (en) Process for the recovery of 2,6-dimethylphenol
DE3060550D1 (en) Process for the preparation of 2-formyl-3.3-dimethyl-cyclopropanecarboxylic acid esters
GB1521558A (en) Process for the production of o-derivatives of rho-isopropenyl phenol
MY7800020A (en) Preparation of 3, 6-dichloropicolinic acid
GR58256B (en) Process for the production of dioxyclavulanic acid
GB1546106A (en) Process for the preparation of dithiophosphoric acid ester dihalides
CS191211B2 (en) Method of production of the 0,0-dimethyl-event. 0,0-diethyl-0-/2,2-dichlorvinyl/esters of the thionofosfor for acid
JPS5276484A (en) Production of 33 oxobisnorcolaa1*44dienic acid by microorganism
JPS5223086A (en) Novel method of preparing 2,3- dioxopiperazine